Vifor Pharma is a world leader in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency. The company also offers a diversified portfolio of prescription medicines as well as non-prescription medicines. The Group also has a focus on the management of conditions in nephrology, cardiology and rare diseases.
Vifor Pharma's operational headquarters are in Zurich, Switzerland, and the company has an increasingly global presence and a broad network of affiliates and partners around the world.
Rechenstrasse 37, 9014 St. Gallen – Switzerland
|Date||Trading entity / Person||Association||Trade type||Volume|
|09.03.22||None||Executive member||Sell||CHF 4,335,210.00|
|09.03.22||None||Non-Executive member||Sell||CHF 1,951,125.00|
|09.03.22||None||Non-Executive member||Sell||CHF 1,851,300.00|
|09.03.22||None||Executive member||Sell||CHF 1,535,160.00|
|09.03.22||None||Non-Executive member||Sell||CHF 1,450,515.00|
|09.03.22||None||Executive member||Sell||CHF 920,205.00|
|09.03.22||None||Executive member||Sell||CHF 530,310.00|
|09.03.22||None||Non-Executive member||Sell||CHF 382,140.00|
|09.03.22||None||Non-Executive member||Sell||CHF 330,495.00|
|09.03.22||None||Executive member||Sell||CHF 287,925.00|
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.